Amy Bian

Arbaclofen Placarbil in GERD: A Randomized, Double-Blind, Placebo-Controlled Study

Nimish Vakil, F Jacob Huff, Amy Bian et al. · The American Journal of Gastroenterology · 2011 · 58 citations

A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis

Jeremy M. Shefner, Andrew A. Wolff, Lisa Meng et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2016 · 42 citations

Improved stratification of <scp>ALS</scp> clinical trials using predicted survival

James D. Berry, Albert A. Taylor, Danielle Beaulieu et al. · Annals of Clinical and Translational Neurology · 2018 · 28 citations · Full text

VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics

Jinsy Andrews, Merit Cudkowicz, Orla Hardiman et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2018 · 25 citations · Full text

Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insurance

Lisa Meng, Amy Bian, Scott Jordan et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2017 · 22 citations · Full text